IndyGeneUS Bio

IndyGeneUS Bio CEO and CTO ...

What if 88% of humanity represents one of medicine’s greatest untapped opportunities?

For decades, the genomic datasets powering drug discovery, precision medicine and now AI have been built from only a fraction of the world’s biological diversity.

That isn’t just a representation problem.

It’s a data problem, a discovery problem, and increasingly, an economic opportunity.

At IndyGeneUS Bio, we believe the next frontier of medicine will be built by expanding the biological intelligence available to science—and creating the infrastructure to responsibly turn that intelligence into discovery.

The missing data may hold some of the answers medicine has been searching for.

Read the full article:
"Biological Alpha: The Missing 88% and the Race to Unlock Medicine’s Most Valuable Genomic Intelligence"

ArtificialIntelligence DrugDiscovery Biotechnology

Meet our founder at the 9th Annual Black Blockchain Summit on Saturday, September 26th, at Howard University!

This panel will dive into "Blockchain as the Trust Layer for AI: Why Decentralisation Makes AI Safe for Black Communities"

We hope to see you there.

Thank you BioBuzz for highlighting the work of IndyGeneUS Bio and our innovative founder, Yusuf Henriques!

Check out the article: https://lnkd.in/edw6A_GC

We're proud to welcome Julius Maina as our new Strategic Advisor, where he'll help drive the commercial ex*****on of our Clinico-Genomic Insights Engine™ (CGIE™) and expand strategic partnerships that advance the future of representative genomic intelligence.

As precision medicine evolves, transforming breakthrough science into real-world impact requires more than innovation—it requires thoughtful commercialization, collaboration, and ex*****on.

We're excited to have Julius helping lead that journey.

We're proud to welcome Julius Maina as our new Strategic Advisor, where he'll help drive the commercial ex*****on of our Clinico-Genomic Insights Engine™ (CGIE™) and expand strategic partnerships that advance the future of representative genomic intelligence.

As precision medicine evolves, transforming breakthrough science into real-world impact requires more than innovation—it requires thoughtful commercialization, collaboration, and ex*****on.

We're excited to have Julius helping lead that journey.

Read the full announcement here: IndyGeneUS Bio appoints Julius Maina Strategic Advisor⁠�

Today, the IndyGeneUS Bio team is elated to welcome Dr George Church to our Scientific Advisory Board.

Widely regarded as the "Godfather of Genomics," Dr. Church helped pioneer modern genome sequencing and was the first scientist to sequence an entire human genome.

Happy to announce that our founder will be speaking at HITLAB’s virtual July Symposium: Digital Pharmacy, Medication Safety & Healthcare Logistics.

It is free to attend! Use the link below to register. https://www.hitlab.org/july26-symp/

Earlier this week IndyGeneUS Bio and the NATIONAL BIOTECHNOLOGY RESEARCH AND DEVELOPMENT AGENCY (NBRDA) signed and MOU to establish a National Genomics and Bioinformatics Data Infrastructure aimed at strengthening innovation in healthcare, agriculture, and biotechnology while positioning Nigeria as a key player in the global bioeconomy.

The signing took place during a formal press conference at the National Biotechnology Research and Development Agency headquarters in Abuja, Nigeria.

https://youtu.be/vxI0Kf-WjJ4?si=QtmVgBX4D6WbxfMf

Midweek Meditation ✨ Focus

Focus is a form of respect — for your time, energy, and purpose.

In a world full of distractions, give your attention to what truly matters today. Simplify. Refocus. Be present.

Reflection Prompt:
What’s pulling your attention away from what matters most?- https://mailchi.mp/alive/dont-give-up-try-this-18007945